サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ワクチンアジュバント市場：製品タイプ別、用途別、疾患領域別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1419053

ワクチンアジュバント市場：製品タイプ別、用途別、疾患領域別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Vaccine Adjuvants Market, By Product Type, By Application, By Usage Type, By Disease Area, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 325 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
ワクチンアジュバント市場：製品タイプ別、用途別、疾患領域別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2024年01月01日
発行: AnalystView Market Insights
ページ情報: 英文 325 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ワクチンアジュバントの市場規模は2022年に7億1,250万米ドルとなり、2023年から2030年にかけてCAGR 7.2％で拡大する見込みです。

ワクチンアジュバント市場-市場力学

感染症の流行が市場需要を促進

インフルエンザ、結核、コレラ、ポリオ、麻疹、マラリア、HIVなどの感染症の流行が拡大しています。WHOによると、結核は世界第13位の死因であり、2021年にはCOVID-19に次いで第2位の感染性死因となり、HIV感染者18万7,000人を含め、世界中で約160万人の死亡が報告されています。このような伝染病と闘うためには、より多くのワクチンが必要であり、その結果、アジュバントの需要が高まっています。

ワクチンアジュバント市場-セグメンテーション分析：

ワクチンアジュバントの世界市場は、製品タイプ、用途、使用タイプ、疾患領域、地域に基づいてセグメント化されます。

市場は製品タイプによって8つのカテゴリーに分類されます：ミネラル塩ベースのアジュバント、テンソアクティブアジュバント、アジュバントエマルジョン、リポソームアジュバント、炭水化物アジュバント、細菌由来アジュバント、ウイルス様粒子（VLP）、その他。製品分類に基づくと、アジュバントエマルション部門は前計画期間中、主導的地位を維持すると予測されます。これは主に、伝染病の流行が拡大し、ワクチンにおけるエマルジョンアジュバントの使用が促進され、その結果、この特定セグメントの拡大が促進されたためです。

同市場は、用途によって研究用と商業用の2つに分類されます。商用分野が市場を独占しており、予測期間中もその優位性は維持されると思われます。感染症が増加し、公衆衛生上の懸念が世界的に高まる中、効果的なワクチンの必要性が高まっています。アジュバントは、予防効果を高めるワクチンの開発に大きく貢献し、特に感染症の流行が高い地域で、ヘルスケアシステムがワクチン接種プログラムを拡大することを可能にします。

ワクチンアジュバント市場-地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

ワクチンアジュバント市場-競合情勢：

ワクチンアジュバント市場は現在、ワクチンの有効性と安全性を高めるための戦略的進歩を遂げています。これらの技術革新は、安全基準を維持しながら免疫反応を強化することを目的とした、アジュバントの製剤と送達システムの開拓に集中しています。重要な研究開発は、アジュバントをそれぞれのワクチンに特化して調整することで、多様な人口集団におけるワクチンの有効性を高めることに向けられています。さらに、製薬会社、研究機関、規制当局の連携により、特に新興感染症や課題となっている病原体に対するアジュバントの開発と検証が推進されています。市場力学の中心は規制順守、コスト効率、拡張性であり、ワクチン応答を強化し、世界の公衆衛生の向上に貢献する革新的なアジュバント技術の舞台を整えています。

目次

第1章 ワクチンアジュバント市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ワクチンアジュバントの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 ワクチンアジュバント産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ワクチンアジュバント市場：COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 ワクチンアジュバント市場情勢

  • ワクチンアジュバント市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ワクチンアジュバント市場：製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • ミネラル塩ベースのアジュバント
    • 張力活性アジュバント
    • アジュバントエマルジョン
    • リポソームアジュバント
    • 炭水化物アジュバント
    • 細菌由来のアジュバント
    • ウイルス様粒子（VLP）
    • その他

第8章 ワクチンアジュバント市場：用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 研究用途
    • 商用

第9章 ワクチンアジュバント市場：使用タイプ別

  • 概要
    • 使用タイプ別のセグメントシェア分析
    • 活性免疫賦活剤
    • キャリア
    • ビヒクルアジュバント

第10章 ワクチンアジュバント市場：疾患領域別

  • 概要
    • 疾患領域別のセグメントシェア分析
    • 感染症
    • がん
    • その他

第11章 ワクチンアジュバント市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- ワクチンアジュバント業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Associated British Foods Plc（spi Pharma Inc.）
    • Adjuvatis
    • Agenus Inc.
    • Aphios Corporation
    • Vertellus
    • Croda International PLC
    • CSL Limited
    • Dynavax Technologies Corporation
    • GlaxoSmithKline PLC
    • InvivoGen
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Vaccine Adjuvants Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Vaccine Adjuvants Market, by Product Type 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Vaccine Adjuvants Market, by Application 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Usage Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Usage Type
  • TABLE Global Vaccine Adjuvants Market, by Usage Type 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Disease Area Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Area
  • TABLE Global Vaccine Adjuvants Market, by Disease Area 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Vaccine Adjuvants Market, by Region 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)

List of Figures

  • FIGURE Vaccine Adjuvants Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Usage Type segment market share analysis, 2022 & 2030
  • FIGURE Usage Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Disease Area segment market share analysis, 2022 & 2030
  • FIGURE Disease Area segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Europe Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Asia Pacific Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Latin America Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Middle East and Africa Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE Germany Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE India Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE Brazil Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE Saudi Arabia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2118

REPORT HIGHLIGHT

Vaccine Adjuvants Market size was valued at USD 712.5 Million in 2022, expanding at a CAGR of 7.2% from 2023 to 2030.

Vaccine adjuvants are components integrated into vaccines to heighten the body's immune response triggered by the vaccine's antigen, which stimulates the immune system. These adjuvants function by amplifying the body's immune reaction, thereby enhancing the vaccine's effectiveness by bolstering the immune response and often permitting the use of smaller antigen amounts. They can induce a more robust and longer-lasting immune response, thereby elevating defense against the targeted disease. Adjuvants also aid in enhancing vaccine efficacy for specific populations, such as the elderly or individuals with compromised immune systems. Diverse adjuvant types encompass aluminum salts (like aluminum hydroxide or aluminum phosphate), oil-in-water emulsions (such as MF59 or AS03), toll-like receptor agonists, among others. Adjuvants are pivotal in vaccine development, facilitating the creation of more potent vaccines against various infectious diseases and augmenting overall vaccine effectiveness and the endurance of immune responses.

Vaccine Adjuvants Market- Market Dynamics

Increasing prevalence of infectious diseases to propel market demand

The prevalence of infectious diseases like influenza, tuberculosis, cholera, polio, measles, malaria, and HIV has escalated. According to the WHO, TB ranked as the 13th leading cause of death globally and stood as the second-leading infectious cause of death after COVID-19 in 2021, with almost 1.6 million reported deaths worldwide, including 187,000 individuals with HIV. The surge in cases has put immense pressure on vaccine production, as an increased number of vaccines are necessary to combat such contagious diseases, consequently heightening the demand for adjuvants.

Vaccine Adjuvants Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.2% over the forecast period (2023-2030)
  • Based on product type segmentation, adjuvant emulsions was predicted to show maximum market share in the year 2022
  • Based on application segmentation, commercial was the leading type in 2022
  • Based on Usage Type segmentation, Active Immunostimulants was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Vaccine Adjuvants Market- Segmentation Analysis:

The Global Vaccine Adjuvants Market is segmented on the basis of Product Type, Application, Usage Type, Disease Area, and Region.

The market is divided into eight categories based on product type: Mineral Salt-based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-derived Adjuvants, Virus-like Particles (VLP) and Others. Based on product categorization, the adjuvant emulsions segment is forecasted to uphold its leading position during he forecat period. This is primarily accredited to the escalating prevalence of communicable diseases, propelling the usage of emulsion adjuvants in vaccines and consequently nurturing the expansion of this specific segment.

The market is divided into two categories based on application: research and commercial. The commercial sector dominates the market and is likely to maintain its dominance during the forecast period. With the rise in infectious diseases and ongoing public health concerns globally, there's a growing need for effective vaccines. Adjuvants contribute significantly to developing vaccines that offer improved protection, enabling healthcare systems to expand vaccination programs, especially in regions where there is a high prevalence of infectious diseases.

Vaccine Adjuvants Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Vaccine Adjuvants Market- Competitive Landscape:

The market for vaccine adjuvants is currently undergoing strategic advancements directed at enhancing both the efficacy and safety of vaccines. These innovations concentrate on pioneering adjuvant formulations and delivery systems, aiming to intensify immune responses while upholding safety standards. Significant research and development endeavors are directed towards tailoring adjuvants specifically for distinct vaccines, thereby augmenting their effectiveness across diverse demographic groups. Moreover, collaborations among pharmaceutical firms, research institutions, and regulatory bodies are propelling the development and validation of adjuvants, especially for emerging infectious diseases and challenging pathogens. Market dynamics center around regulatory adherence, cost-efficiency, and scalability, setting the stage for transformative adjuvant technologies that fortify vaccine responses and contribute to global public health improvements.

Recent Developments:

In January 2023, Elicio Therapeutics, specializing in lymph node-targeted adjuvants as well as vaccines for violent cancers along with infectious illnesses, finalized a union agreement with Angion Biomedica Corp. The focus lies on advancing Elicio's exclusive lymph node-targeting Amphiphile expertise to progress immunotherapies, primarily concentrating on ELI-002, a therapeutic cancer vaccine aimed at mKRAS-driven tumors.

In November 2022, Hubro Therapeutics AS acquired the GM-CSF vaccine adjuvant from Targovax ASA through an asset purchase agreement, involving a cash payment of NOK10 million. Hubro is continuing the development of GM-CSF as an adjuvant for its range of innovative cancer vaccines in its pipeline.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VACCINE ADJUVANTS MARKET KEY PLAYERS

  • Associated British Foods Plc (spi Pharma Inc.)
  • Adjuvatis
  • Agenus Inc.
  • Aphios Corporation
  • Vertellus
  • Croda International PLC
  • CSL Limited
  • Dynavax Technologies Corporation
  • GlaxoSmithKline PLC
  • InvivoGen
  • Others

GLOBAL VACCINE ADJUVANTS MARKET, BY PRODUCT TYPE

  • Mineral Salt-based Adjuvant
  • Tensoactive Adjuvants
  • Adjuvant Emulsions
  • Liposome Adjuvants
  • Carbohydrate Adjuvants
  • Bacteria-derived Adjuvants
  • Virus-like Particles (VLP)
  • Others

GLOBAL VACCINE ADJUVANTS MARKET, BY APPLICATION

  • Research Applications
  • Commercial Applications

GLOBAL VACCINE ADJUVANTS MARKET, BY USAGE TYPE

  • Active Immunostimulants
  • Carriers
  • Vehicle Adjuvants

GLOBAL VACCINE ADJUVANTS MARKET, BY DISEASE AREA

  • Infectious Disease
  • Cancer
  • Others

GLOBAL VACCINE ADJUVANTS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Vaccine Adjuvants Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Vaccine Adjuvants Market Snippet by Product Type
    • 2.1.2. Vaccine Adjuvants Market Snippet by Application
    • 2.1.3. Vaccine Adjuvants Market Snippet by Usage Type
    • 2.1.4. Vaccine Adjuvants Market Snippet by Disease Area
    • 2.1.5. Vaccine Adjuvants Market Snippet by Country
    • 2.1.6. Vaccine Adjuvants Market Snippet by Region
  • 2.2. Competitive Insights

3. Vaccine Adjuvants Key Market Trends

  • 3.1. Vaccine Adjuvants Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Vaccine Adjuvants Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Vaccine Adjuvants Market Opportunities
  • 3.4. Vaccine Adjuvants Market Future Trends

4. Vaccine Adjuvants Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Vaccine Adjuvants Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Vaccine Adjuvants Market Landscape

  • 6.1. Vaccine Adjuvants Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Vaccine Adjuvants Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Mineral Salt-based Adjuvant
    • 7.1.3. Tensoactive Adjuvants
    • 7.1.4. Adjuvant Emulsions
    • 7.1.5. Liposome Adjuvants
    • 7.1.6. Carbohydrate Adjuvants
    • 7.1.7. Bacteria-derived Adjuvants
    • 7.1.8. Virus-like Particles (VLP)
    • 7.1.9. Others

8. Vaccine Adjuvants Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Research Applications
    • 8.1.3. Commercial Applications

9. Vaccine Adjuvants Market - By Usage Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Usage Type, 2022 & 2030 (%)
    • 9.1.2. Active Immunostimulants
    • 9.1.3. Carriers
    • 9.1.4. Vehicle Adjuvants

10. Vaccine Adjuvants Market - By Disease Area

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 10.1.2. Infectious Disease
    • 10.1.3. Cancer
    • 10.1.4. Others

11. Vaccine Adjuvants Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Vaccine Adjuvants Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Vaccine Adjuvants Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Vaccine Adjuvants Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Vaccine Adjuvants Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Vaccine Adjuvants Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Vaccine Adjuvants Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Associated British Foods Plc (spi Pharma Inc.)
    • 12.2.2. Adjuvatis
    • 12.2.3. Agenus Inc.
    • 12.2.4. Aphios Corporation
    • 12.2.5. Vertellus
    • 12.2.6. Croda International PLC
    • 12.2.7. CSL Limited
    • 12.2.8. Dynavax Technologies Corporation
    • 12.2.9. GlaxoSmithKline PLC
    • 12.2.10. InvivoGen
    • 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us